I just sent: "Brain Cell Transplants Help Parkinson's Patients" and now we have... Skull Surgery Fails for Parkinson's By JANET McCONNAUGHEY, Associated Press Writer March 7, 2001 An experimental treatment for Parkinson's in which holes are drilled in the skull and cells from aborted fetuses are implanted in the brain does not cure the disease, according to a controversial new study. The study had raised ethical questions because some participants, for the sake of comparison, underwent sham surgery in which mere indentations were drilled in their heads. The implanted stem cells - cells that can develop into many types of tissue - survived and grew into the right kind of brain cells. But they did not help patients older than 60. Younger patients - who make up about 40 percent of the 60,000 people diagnosed each year in the United States - improved a bit, but only for a year. After that, the cells apparently did their job too well in some patients, causing excess movements because they produced more of the needed nerve transmitter dopamine than the body could use. "There was tremendous hope that stem cell therapy could be a cure. This study really points out the problems we have to solve before that can happen,'' said neurologist Dr. J. William Langston, founder of the Parkinson's Institute in Sunnyvale, Calif. The study was conducted by doctors at Columbia University and the University of Colorado and was published in Thursday's New England Journal of Medicine. Dr. Curt R. Freed, who led the study as director of the University Of Colorado Neurotransplantation Center for Parkinson's Disease, has begun work to see if he gets better results by dripping the cells into other parts of the brain. Langston said the results indicate that stem cell research for Parkinson's should go back to the animal laboratory. Parkinson's disease whose sufferers include former Attorney General Janet Reno and actor Michael J. Fox, is a progressive brain disease marked by tremors, stiffness, slowness and loss of balance. The symptoms grow as the brain loses cells that produce dopamine, a transmitter that carries messages to the nerve cells controlling motion. Medicine can reduce or eliminate some symptoms for a while by helping the brain produce more dopamine. But after four to eight years, the medicine itself causes tremors and other side effects, and eventually it no longer helps. The patient cannot move, speak or swallow. In the new study, 20 patients received the operation, in which four holes are drilled in the skull. Twenty others underwent sham surgery, in which the drill did not go all the way through. Fourteen of the 20 in the sham-surgery group got real transplants later. (Fox underwent a different type of surgery - a thalamotomy, a decades-old operation that destroys overactive, tremor-causing nerve cells by burning or freezing a pea-size spot in the brain.) Some doctors said that because of the pain and the risk of complications, it is unethical to perform sham operations, even though patients knew ahead of time they had only a 50-50 chance of getting a transplant. Others said sham surgery is the only way to get a valid comparison and account for the so-called placebo effect, in which patients feel better simply because they are being treated, even if the treatment is a dummy medicine, such as a flour pill or a water injection. None of the patients in the Parkinson's suffered any ill effects from the sham surgery. Langston said the study showed that the procedure itself is safe and that the grafts survive. "It was a pioneering study and one that I think was desperately needed in the field,'' he said. ``It was the first really controlled trial of this type of surgery.'' On the Net: University of Colorado School of Medicine: http://www.uchsc.edu/ Parkinson's Institute: http://www.parkinsonsinstitute.org/ New England Journal of Medicine: http://www.nejm.org Email this story - View most popular | Printer-friendly format Copyright © 2001 The Associated Press. -- Judith Richards, London, Ontario, Canada [log in to unmask] Today’s Research... Tomorrow’s Cure